Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)
- PMID: 11318837
- DOI: 10.1046/j.1464-5491.2001.00458.x
Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)
Abstract
Aim: to establish the degree to which the severity of retinopathy determines the risk for the need for subsequent photocoagulation in those with newly diagnosed Type 2 diabetes mellitus.
Methods: Of 5102 patients entered into the UK Prospective Diabetes Study (UKPDS), 3709 had good quality retinal photographs that could be graded at entry. They were followed until the end of the study or until lost to follow-up, or until they received photocoagulation. Retinopathy severity was categorized as no retinopathy, microaneurysms (MA) only in one eye, MA in both eyes or more severe retinopathy features. The risk of photocoagulation was assessed in relation to severity of retinopathy at baseline, 3 and 6 years.
Results: Of the 3709 patients assessed at entry to the UKPDS, 2316 had no retinopathy. Of these 0.2% needed photocoagulation at 3 years, 1.1% at 6 years and 2.6% at 9 years. Those with MA in one eye only (n = 708) were similar, with 0%, 1.9% and 4.7% needing photocoagulation by 3, 6 and 9 years, respectively. Amongst those who had more retinopathy features at entry (n = 509), 15.3% required photocoagulation by 3 years, and 31.9% by 9 years. When those without retinopathy at 6 years (n = 1579) were examined 3 and 6 years later (9 and 12 years after diagnosis), 0.1% and 1.8% required photocoagulation. Those with more severe retinopathy (n = 775) needed earlier treatment, 6.6% after 3 years and 13.3% after 9 years. The commonest indication for laser therapy was maculopathy, but those with more severe retinopathy were more likely to be treated for proliferative retinopathy and to need both eyes treated.
Conclusion: Few type 2 diabetic patients without retinopathy progress to photocoagulation in the following 3-6 years, while patients with more severe retinopathy lesions need to be monitored closely.
Similar articles
-
Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.Diabetologia. 1999 Sep;42(9):1107-12. doi: 10.1007/s001250051278. Diabetologia. 1999. PMID: 10447523 Clinical Trial.
-
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.Arch Ophthalmol. 2004 Nov;122(11):1631-40. doi: 10.1001/archopht.122.11.1631. Arch Ophthalmol. 2004. PMID: 15534123 Clinical Trial.
-
Microvascular disease: what does the UKPDS tell us about diabetic retinopathy?Diabet Med. 2008 Aug;25 Suppl 2:20-4. doi: 10.1111/j.1464-5491.2008.02505.x. Diabet Med. 2008. PMID: 18717974
-
Lowering the risk of visual impairment and blindness.Diabet Med. 1998;15 Suppl 4:S47-50. doi: 10.1002/(sici)1096-9136(1998120)15:4+<:aid-dia739>3.3.co;2-j. Diabet Med. 1998. PMID: 9868992 Review.
-
Pharmacological approach to diabetic retinopathy.Diabetes Metab Res Rev. 2004 Mar-Apr;20(2):91-113. doi: 10.1002/dmrr.432. Diabetes Metab Res Rev. 2004. PMID: 15037985 Review.
Cited by
-
Willingness to pay for diabetic retinopathy screening in Qujiang District, rural Guangdong, southern China: a cross-sectional study.BMJ Open. 2023 Apr 25;13(4):e065792. doi: 10.1136/bmjopen-2022-065792. BMJ Open. 2023. PMID: 37185202 Free PMC article.
-
Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy.Ophthalmol Sci. 2023 Feb 1;3(2):100276. doi: 10.1016/j.xops.2023.100276. eCollection 2023 Jun. Ophthalmol Sci. 2023. PMID: 36950087 Free PMC article.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
-
Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review.Diabetes Ther. 2022 Jan;13(1):1-23. doi: 10.1007/s13300-021-01190-z. Epub 2021 Dec 20. Diabetes Ther. 2022. PMID: 34928488 Free PMC article. Review.
-
Imaging Modalities Employed in Diabetic Retinopathy Screening: A Review and Meta-Analysis.Diagnostics (Basel). 2021 Sep 29;11(10):1802. doi: 10.3390/diagnostics11101802. Diagnostics (Basel). 2021. PMID: 34679501 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical